L'Oréal Dermatological Beauty Pro is a community full of continuing medical education, patient resources, medical events, and more that support and empower healthcare professionals in their daily practice of dermatology.
Adjunctive therapy for acne in daily practice: Key issues for effective patient management
- 20min
- Supported by
Acne and many of its treatments (i.e. benzoyl peroxide, topical retinoids, and oral isotretinoin) can impair the stratum corneum (SC) permeability barrier.1
Why do we recommend dermocosmetics as adjuvant to therapy to acne patients?
Although much more research is needed on the structural and functional integrity of the SC and epidermal barrier functions inherent to acne-prone skin, there is some evidence of SC permeability impairment innate to acne and/or the inflammation that occurs in association with acne.1
In addition, studies show a rapid and dramatic improvement in QoL scores when used properly in addition to other therapies. Because improvement in QoL is related to patient satisfaction and compliance with medical treatment, make-up at the onset of treatment in specific cases may help increase patient satisfaction and yield improved clinical results.2
In addition:
